Abbott Laboratories has agreed to pay $385 million to settle legal claims related to a 2022 baby formula shortage caused by a recall at its Sturgis, Michigan plant. The Justice Department initiated a lawsuit amid concerns over bacterial contamination, leading to a nationwide recall of Abbott's major infant formula brands like Similac and exacerbating existing supply chain issues. While the settlement does not admit…
Baby formula maker Abbott Labs agrees to settlement over closure of largest US plant (this article)
